Black Rock Inc. Heron Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,325,385 shares of HRTX stock, worth $10.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,325,385
Previous 7,286,028
14.27%
Holding current value
$10.9 Million
Previous $20.2 Million
44.38%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding HRTX
# of Institutions
185Shares Held
130MCall Options Held
1.56MPut Options Held
27.1K-
Rubric Capital Management LP New York, NY26.7MShares$35 Million1.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.47MShares$11.1 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.85MShares$10.3 Million0.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$9.15 Million24.86% of portfolio
-
Palisade Capital Management LLC Fort Lee, NJ5.09MShares$6.66 Million0.36% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $156M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...